Comments to the CFDA's Draft Regulation on ”Protection of Confidentiality during Evaluation, Examination & Approval of Pharmaceuticals and Medical Devices”

2017-01-11 | Beijing

The Healthcare Equipment and Pharmaceutical Working Groups submitted comments to the CFDA's Draft Regulation on ”Protection of Confidentiality during Evaluation, Examination & Approval of Pharmaceuticals and Medical Devices”

The recommendations focused on the range of data that should be protected by the regulation as well as the time previous officers of the CFDA shall be obligated to protect confidentiality after they leave their post.

More information: http://www.cfda.gov.cn/WS01/CL0783/168125.html